Protillion Biosciences
Protillion Biosciences is a biotechnology company that commercializes a high-throughput protein discovery and optimization platform for therapeutic antibody and binder discovery. Their proprietary technology enables quantitative analysis of complete protein libraries at massive scale, producing precise protein data with perfect amino acid resolution. This allows for rapid identification and optimization of therapeutic molecules with exquisite specificity, precisely tuned affinity, and manufacturability, accelerating biologic research and development productivity. The platform integrates next-generation sequencing, machine learning, and advanced wet lab experimentation to revolutionize protein drug discovery, reducing timelines from months to days. Protillion is a Stanford University spinout backed by leading venture firms ARCH Venture Partners and Illumina Ventures, positioning it as a leader in the next generation of protein therapeutics discovery.
Protillion Biosciences
Protillion Biosciences is a biotechnology company that commercializes a high-throughput protein discovery and optimization platform for therapeutic antibody and binder discovery. Their proprietary technology enables quantitative analysis of complete protein libraries at massive scale, producing precise protein data with perfect amino acid resolution. This allows for rapid identification and optimization of therapeutic molecules with exquisite specificity, precisely tuned affinity, and manufacturability, accelerating biologic research and development productivity. The platform integrates next-generation sequencing, machine learning, and advanced wet lab experimentation to revolutionize protein drug discovery, reducing timelines from months to days. Protillion is a Stanford University spinout backed by leading venture firms ARCH Venture Partners and Illumina Ventures, positioning it as a leader in the next generation of protein therapeutics discovery.